NCT07770698 A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07575971 Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment After First Remission in High-Risk B-Cell Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE1/PHASE2
NCT07575919 Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL Status RECRUITING Phase PHASE1/PHASE2
NCT07570173 A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005) Status RECRUITING Phase PHASE2/PHASE3
NCT07429461 Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia Status RECRUITING Phase EARLY_PHASE1
NCT07422337 A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab Status RECRUITING Phase N/A
NCT07313852 A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07223021 A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE3
NCT07153796 A Phase 1b/2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT07043218 A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia Status NOT_YET_RECRUITING Phase PHASE1
NCT06879340 Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies Status RECRUITING Phase PHASE1
NCT06863259 Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL Status RECRUITING Phase PHASE1
NCT06793241 Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia Status RECRUITING Phase EARLY_PHASE1
NCT06608732 Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission. Status RECRUITING Phase PHASE2
NCT06581081 Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia Status RECRUITING Phase NA
NCT06580301 Study of YK012 in B-cell Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE1/PHASE2
NCT06559644 Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06559189 CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL Status RECRUITING Phase PHASE1
NCT06533579 Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19) Status RECRUITING Phase PHASE1/PHASE2